Literature DB >> 34449307

The latest information on the RIPK1 post-translational modifications and functions.

Qiong Wang1, Danping Fan2, Ya Xia1, Qinbin Ye1, Xiaoyu Xi1, Guoqiang Zhang3, Cheng Xiao4.   

Abstract

RIPK1 is a protein kinase that simultaneously regulates inflammation, apoptosis, and necroptosis. It is thought that RIPK1 has separate functions through its scaffold structure and kinase domains. Moreover, different post-translational modifications in RIPK1 play distinct or even opposing roles. Under different conditions, in different cells and species, and/or upon exposure to different stimuli, infections, and substrates, RIPK1 activation can lead to diverse results. Despite continuous research, many of the conclusions that have been drawn regarding the complex interactions of RIPK1 are controversial. This review is based on an examination and analysis of recent studies on the RIPK1 structure, post-translational modifications, and activation conditions, which can affect its functions. Finally, because of the diverse functions of RIPK1 and their relevance to the pathogenesis of many diseases, we briefly introduce the roles of RIPK1 in inflammatory and autoimmune diseases and the prospects of its use in future diagnostics and treatments.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Apoptosis; Inflammation; Necroptosis; Post-translational modifications; Receptor-interacting protein kinase 1

Mesh:

Substances:

Year:  2021        PMID: 34449307     DOI: 10.1016/j.biopha.2021.112082

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Novel RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-03-02       Impact factor: 4.345

2.  The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis.

Authors:  Valeria Pistorio; Juliette Tokgozoglu; Vlad Ratziu; Jérémie Gautheron
Journal:  J Mol Med (Berl)       Date:  2022-06-15       Impact factor: 5.606

3.  ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1.

Authors:  Zhonghui Zhang; Liang Zhong; Wenran Dan; Xuan Chu; Chen Liu; Xu Luo; Peng Wan; Zhenyan Liu; Yang Lu; Xiao Wang; Beizhong Liu
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

Review 4.  Aberrant expression of miRNAs in epilepsy.

Authors:  Soudeh Ghafouri-Fard; Bashdar Mahmud Hussen; Atefe Abak; Mohammad Taheri; Reza Jalili Khoshnoud
Journal:  Mol Biol Rep       Date:  2022-01-28       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.